Search

Search Constraints

You searched for: Author/Creator Vermorken, Jan B

Search Results

1. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial. Issue 5 (May 2015)